Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash from Operations (2021 - 2025)

Historic Cash from Operations for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $131.8 million.

  • Core Scientific's Cash from Operations rose 220668.65% to $131.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.0 million, marking a year-over-year increase of 17362.88%. This contributed to the annual value of $42.9 million for FY2024, which is 3412.17% down from last year.
  • As of Q3 2025, Core Scientific's Cash from Operations stood at $131.8 million, which was up 220668.65% from $34.0 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Cash from Operations ranged from a high of $144.9 million in Q2 2022 and a low of -$136.7 million during Q2 2021
  • In the last 5 years, Core Scientific's Cash from Operations had a median value of $15.4 million in 2021 and averaged $20.1 million.
  • The largest annual percentage gain for Core Scientific's Cash from Operations in the last 5 years was 272392.03% (2025), contrasted with its biggest fall of 28309.28% (2025).
  • Core Scientific's Cash from Operations (Quarter) stood at $109.7 million in 2021, then rose by 5.69% to $116.0 million in 2022, then plummeted by 81.29% to $21.7 million in 2023, then plummeted by 36.39% to $13.8 million in 2024, then skyrocketed by 854.59% to $131.8 million in 2025.
  • Its Cash from Operations was $131.8 million in Q3 2025, compared to $34.0 million in Q2 2025 and -$40.6 million in Q1 2025.